Over the counter artificial tears market to reach $6.53 billion by 2030 at 5.7% cagr, driven by increasing prevalence of eye diseases and vision impairment.
Read More
Over the counter analgesics market to reach $45.91 billion by 2030 at 6.0% cagr, driven by growing consumer preference for self-medication.
Read More
Over the counter topical drugs market to reach $101.09 billion by 2030 at 9.7% cagr, driven by increasing incidence of skin cancer and related conditions.
Read More
Over the counter drugs market to reach $216.97 billion by 2030 at 5.3% cagr, driven by rising prevalence of lifestyle-related health issues globally.
Read More
Ovarian cancer drugs market to reach $11.53 billion by 2030 at 14.8% cagr, driven by government initiatives and funding for ovarian cancer research.
Read More
Otic drugs market to reach $2.59 billion by 2030 at 7.5% cagr, driven by rising prevalence rate of ear infections and hearing-related disorders.
Read More
Otc dry eye drops market to reach $5.33 billion by 2030 at 7.0% cagr, driven by increasing screen exposure and growing digital eye strain.
Read More
Otc drug and dietary supplement market to reach $497.84 billion by 2030 at 7.2% cagr, driven by rising pharma research and development expenditure globally.
Read More
Osteoporosis drugs market to reach $16.21 billion by 2030 at 4.3% cagr, driven by surging prevalence of osteoporosis among aging populations worldwide.
Read More
Osteogenesis imperfecta treatment market to reach $1.16 billion by 2030 at 4.3% cagr, driven by increasing prevalence of osteogenesis imperfecta due to improved genetic diagnosis.
Read More